Welcome to our dedicated page for Eastman Chem Co SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Eastman Chemical Company (EMN) SEC filings page provides access to the company’s regulatory disclosures as a public issuer on the New York Stock Exchange. As a global specialty materials company in the plastics material and resin manufacturing industry, Eastman files periodic and current reports that describe its financial condition, results of operations, governance matters, and material events.
Among the most closely watched documents are annual reports on Form 10-K and quarterly reports on Form 10-Q, which include segment information, discussions of end-market demand in areas such as transportation, building and construction, and consumables, and commentary on topics like cash generation, cost structure, and specialty materials performance. Current reports on Form 8-K provide timely updates on specific events, including quarterly earnings releases, Board and executive changes, and other matters the company deems material.
Investors can also review proxy statements for information on Board composition, committee assignments, and director compensation, as well as filings related to executive compensation and governance. For those monitoring insider activity, Forms 3, 4, and 5 disclose transactions by directors and officers in Eastman’s common stock.
On this page, AI-powered tools summarize lengthy filings, highlight key sections, and help explain complex topics such as non-GAAP measures like adjusted EBIT and adjusted earnings per diluted share that Eastman discusses in its earnings materials. Real-time updates from the SEC’s EDGAR system ensure that new EMN filings, including 10-K, 10-Q, 8-K, and Form 4 submissions, are available quickly, allowing users to review the underlying disclosures and the AI-generated insights side by side.
BlackRock, Inc. filed Amendment No. 16 to a Schedule 13G/A reporting beneficial ownership in Eastman Chemical Co. The filing states BlackRock's Reporting Business Units beneficially own 15,745,661 shares of Common Stock, representing 13.8% of the class. The filing lists 15,437,852 shares as sole voting power and identifies iShares Core S&P Small-Cap ETF as a holder with more than 5% of the class. The filing was signed by Spencer Fleming on 04/24/2026.
Eastman Chemical director Damon J. Audia reported routine compensation-related transactions involving cash-settled Phantom Stock Units tied to Eastman Chemical common stock. On April 8, 2026, he acquired 852 units at a reference value of $74.72 per unit and another 408 units. These units reflect voluntary and automatic deferrals of director retainer fees and reinvested dividend equivalents under the company’s Directors' Deferred Compensation Plan, and are payable only in cash after his board service ends. Following these awards, his balance increased to 2,646 Phantom Stock Units, with no open‑market share purchases or sales disclosed.
BUTLER ERIC L reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Eric L. Butler received a grant of 408 Phantom Stock Units as compensation. These units were credited under the Directors' Deferred Compensation Plan as an automatic deferral of a portion of his annual cash retainer fees.
Each Phantom Stock Unit tracks the market value of one share of Eastman Chemical common stock but is payable only in cash after he terminates service as a director. Following this grant and dividend equivalents reinvested in additional units, Butler now holds a total of 3,228 Phantom Stock Units under the plan.
BEGEMANN BRETT D reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Brett D. Begemann increased his deferred compensation balance through phantom stock units rather than cash fees. On April 8, 2026, he was credited with 1,159 Phantom Stock Units valued at $74.27 each and an additional 408 units at $0 under the company’s Directors' Deferred Compensation Plan. These units track the value of one share of Eastman common stock but are payable only in cash after his board service ends. Following these awards and fee deferrals, Begemann holds 58,408 phantom stock units directly, including amounts from voluntary and automatic fee deferrals and reinvested dividend equivalents.
Haynesworth Linnie M reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Linnie M. Haynesworth received 408 Phantom Stock Units on April 8, 2026, as a grant under the company’s Directors’ Deferred Compensation Plan. These units track the value of one share of Eastman common stock but are payable only in cash after board service ends.
The award increased Haynesworth’s Phantom Stock Unit balance to 5,640 units. The grant reflects an automatic deferral of a portion of the director’s annual retainer fees, with dividend equivalents reinvested into additional units, and does not represent an open-market stock purchase or sale.
OBRIEN JAMES J /KY reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director James J. O'Brien received 408 Phantom Stock Units credited under the company’s Directors' Deferred Compensation Plan. These units mirror the market value of one share of common stock each but are payable only in cash after he ceases serving as a director.
The award represents an automatic deferral of a portion of his annual retainer fees that would otherwise have been paid in cash. Following this grant, O'Brien holds a total of 18,137 Phantom Stock Units, which also include dividend equivalents that have been reinvested into additional units.
Alfonso Humberto P reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Humberto P. Alfonso reported two compensation-related grants of Phantom Stock Units tied to company common stock. On April 8, 2026, he was credited with 988 Phantom Stock Units at a reference value of $74.27 per unit and 408 additional units at $0.00 per unit.
After these transactions, his reported Phantom Stock Unit balance increased to 55,961 units. The footnotes explain these units are credited under the Directors' Deferred Compensation Plan, have a value equal to one share of Eastman Chemical common stock, and are payable only in cash after his service as a director ends.
The filing notes these units arise from a mix of voluntary deferral of retainer fees, automatic deferral of annual retainer fees into a director stock account, and dividend equivalents reinvested into additional Phantom Stock Units. These are administrative, non-market transactions rather than open-market share purchases or sales.
Holder Julie Fasone reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical director Julie Fasone Holder received 408 Phantom Stock Units as a compensation award. These units are credited under the Directors' Deferred Compensation Plan, with each unit valued like one share of Eastman common stock but payable only in cash after she leaves the board.
This grant arose from the automatic deferral of a portion of her annual director retainer that would otherwise have been paid in cash, and it also reflects dividend equivalents that are reinvested into additional Phantom Stock Units. Following this award, she now holds a total of 15,051 Phantom Stock Units.
SLAGER DONALD W reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Company director Donald W. Slager received a compensation grant of 408 Phantom Stock Units. These units were credited under the Directors' Deferred Compensation Plan at no purchase price and each unit tracks the value of one share of common stock.
The award represents an automatic deferral of a portion of the director’s annual cash retainer, with amounts payable only in cash after his service as a director ends. Following this grant, Slager holds a total of 1,699 Phantom Stock Units, including units from prior awards and dividend equivalents reinvested in additional units.
HORNBAKER RENEE J reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Company director Renee J. Hornbaker received an award of 408 Phantom Stock Units tied to the value of the company’s common stock. These units were credited under the Directors' Deferred Compensation Plan as an automatic deferral of a portion of her annual retainer fees.
Each Phantom Stock Unit is payable only in cash after she terminates service as a director and includes dividend equivalents reinvested into additional units. After this grant, she holds a total of 51,107 Phantom Stock Units.